TÌNH TRẠNG RỐI LOẠN CƯƠNG DƯƠNG Ở BỆNH NHÂN NAM LỌC MÁU CHU KỲ TẠI BỆNH VIỆN QUÂN Y 103

Abstract

Objectives: To evaluate the prevalence of erectile dysfunction (ED) and analyze its association with certain clinical and paraclinical characteristics in male patients with end stage kidney disease (ESKD) undergoing hemodialysis (HD). Methods: A retrospective, cross-sectional descriptive study was conducted on 57 male patients undergoing stable HD at the Department of Nephrology and Hemodialysis, Military Hospital 103, from October 2023 to October 2024. Results: The prevalence of ED among HD patients was 89.5%. The rates of mild, moderate, and severe ED were 28.1%, 40.4%, and 21.0%, respectively. The median age was 56 years (IQR: 38 - 60) in the ED group, which was statistically higher than 41 years (IQR: 27 - 48) in the non-ED group (p = 0.041). Median serum testosterone was 10.3 nmol/L (IQR: 9.7 - 13.3) in the ED group, which was statistically lower than 13.9 nmol/L (IQR: 12.6 - 16.1) in the non-ED group (p = 0.022). The International Index of Erectile Function-5 (IIEF-5) score showed a moderate positive correlation with hemoglobin and serum albumin concentrations, withcorrelation coefficients, r (p) values of 0.33 (0.01) and 0.38 (0.004), respectively. There was no correlation between ED and serum parathyroid hormone (PTH) and serum phosphorus concentrations, with p > 0.05. Conclusion: HD patients exhibit a very high prevalence of ED, predominantly at a moderate level, which is associated with age, hemoglobin, serum testosterone, and albumin concentrations.